Health Information Technology Advisory Committee 2023 Schedule of Meetings, 33614-33615 [2023-11062]
Download as PDF
<![CDATA[
33614
Federal Register / Vol. 88, No. 100 / Wednesday, May 24, 2023 / Notices
through the formation of its subsidiary
bank, Zenith Bank & Trust, both of
Scottsdale, Arizona.
Estimated Time per Response: The
time per response is estimated at 2.5
person-hours for reporting
requirements.
Total Annual Burden: For the 12
carriers with weekly reporting, the
burden is calculated as 12 × 52 × 2.5
hours = 1,560 hours.
Board of Governors of the Federal Reserve
System.
Ann E. Misback,
Secretary of the Board.
[FR Doc. 2023–11068 Filed 5–23–23; 8:45 am]
William Cody,
Secretary.
BILLING CODE P
ddrumheller on DSK120RN23PROD with NOTICES1
[FR Doc. 2023–11082 Filed 5–23–23; 8:45 am]
BILLING CODE 6730–02–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
FEDERAL RESERVE SYSTEM
Food and Drug Administration
Formations of, Acquisitions by, and
Mergers of Bank Holding Companies
[Docket Nos. FDA–2020–E–2361; FDA–
2020–E–2362; and FDA–2020–E–2363]
The companies listed in this notice
have applied to the Board for approval,
pursuant to the Bank Holding Company
Act of 1956 (12 U.S.C. 1841 et seq.)
(BHC Act), Regulation Y (12 CFR part
225), and all other applicable statutes
and regulations to become a bank
holding company and/or to acquire the
assets or the ownership of, control of, or
the power to vote shares of a bank or
bank holding company and all of the
banks and nonbanking companies
owned by the bank holding company,
including the companies listed below.
The public portions of the
applications listed below, as well as
other related filings required by the
Board, if any, are available for
immediate inspection at the Federal
Reserve Bank(s) indicated below and at
the offices of the Board of Governors.
This information may also be obtained
on an expedited basis, upon request, by
contacting the appropriate Federal
Reserve Bank and from the Board’s
Freedom of Information Office at
https://www.federalreserve.gov/foia/
request.htm. Interested persons may
express their views in writing on the
standards enumerated in the BHC Act
(12 U.S.C. 1842(c)).
Comments regarding each of these
applications must be received at the
Reserve Bank indicated or the offices of
the Board of Governors, Ann E.
Misback, Secretary of the Board, 20th
Street and Constitution Avenue NW,
Washington, DC 20551–0001, not later
than June 23, 2023.
A. Federal Reserve Bank of San
Francisco: (Joseph Cuenco, Assistant
Vice President, Formations &
Transactions) 101 Market Street, San
Francisco, California 94105–1579.
Comments can also be sent
electronically to:
sf.fisc.comments.applications@
sf.frb.org.
1. VB&T Holding Company, LLC; to
become a bank holding company
VerDate Sep<11>2014
18:38 May 23, 2023
Jkt 259001
Determination of Regulatory Review
Period for Purposes of Patent
Extension; ENSPRYNG; Correction
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice; correction.
The Food and Drug
Administration (FDA or the Agency) is
correcting a notice that appeared in the
Federal Register of July 13, 2022. The
document determined the regulatory
review period for ENSPRYNG. After
review of a timely request for
reconsideration by the applicant of the
calculation of the applicable regulatory
review period of the biologic product
ENSPRYNG in that notice, FDA has
determined that a revision of the
supplementary information section is
warranted. This notice corrects the
applicable regulatory review period
language.
SUMMARY:
FOR FURTHER INFORMATION CONTACT:
Beverly Friedman, Office of Regulatory
Policy, Food and Drug Administration,
10903 New Hampshire Ave., Bldg. 51,
Rm. 6250, Silver Spring, MD 20993,
301–796–3600.
SUPPLEMENTARY INFORMATION: In the
Federal Register of July 13, 2022 (87 FR
41724), on page 41725, in the second
column, under ‘‘II. Determination of
Regulatory Review Period,’’ the first two
sentences should be corrected to read as
follows: ‘‘FDA has determined that the
applicable regulatory review period for
ENSPRYNG is 2,494 days. Of this time,
2,128 days occurred during the testing
phase of the regulatory review period,
while 366 days occurred during the
approval phase.’’
Dated: May 18, 2023.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2023–10979 Filed 5–23–23; 8:45 am]
BILLING CODE 4164–01–P
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Information Technology
Advisory Committee 2023 Schedule of
Meetings
Office of the National
Coordinator for Health Information
Technology (ONC), HHS.
ACTION: Notice of meetings.
AGENCY:
The Health Information
Technology Advisory Committee
(HITAC) was established in accordance
with the 21st Century Cures Act and the
Federal Advisory Committee Act. The
HITAC, among other things, identifies
priorities for standards adoption and
makes recommendations to the National
Coordinator for Health Information
Technology (National Coordinator). The
HITAC will hold public meetings
throughout 2023. See list of public
meetings below.
FOR FURTHER INFORMATION CONTACT:
Michael Berry, Designated Federal
Officer, at Michael.Berry@hhs.gov, (202)
701–0795.
SUPPLEMENTARY INFORMATION: Section
4003(e) of the 21st Century Cures Act
(Pub. L. 114–255) establishes the Health
Information Technology Advisory
Committee (referred to as the ‘‘HITAC’’).
The HITAC will be governed by the
provisions of the Federal Advisory
Committee Act (FACA) (Pub. L. 92–
463), as amended, (5 U.S.C. app.), which
sets forth standards for the formation
and use of federal advisory committees.
SUMMARY:
Composition
The HITAC is comprised of at least 25
members, of which:
• No fewer than 2 members are
advocates for patients or consumers of
health information technology;
• 3 members are appointed by the
HHS Secretary:
Æ 1 of whom shall be appointed to
represent the Department of Health and
Human Services and
Æ 1 of whom shall be a public health
official;
• 2 members are appointed by the
majority leader of the Senate;
• 2 members are appointed by the
minority leader of the Senate;
• 2 members are appointed by the
Speaker of the House of Representatives;
• 2 members are appointed by the
minority leader of the House of
Representatives; and
• Other members are appointed by
the Comptroller General of the United
States.
Members serve for one-, two-, or
three-year terms. All members may be
reappointed for a subsequent three-year
E:\FR\FM\24MYN1.SGM
24MYN1
Federal Register / Vol. 88, No. 100 / Wednesday, May 24, 2023 / Notices
term. Each member is limited to two
three-year terms, not to exceed six years
of service. Members serve without pay,
but will be provided per-diem and
travel costs for committee services, if
warranted.
Recommendations
The HITAC recommendations to the
National Coordinator are publicly
available at https://www.healthit.gov/
topic/federal-advisory-committees/
recommendations-national-coordinatorhealth-it.
ddrumheller on DSK120RN23PROD with NOTICES1
Public Meetings
The schedule of meetings to be held
in 2023 is as follows:
• January 19, 2023, from approximately
10:00 a.m. to 3:00 p.m./Eastern Time
(virtual meeting)
• February 8, 2023, from approximately
10:00 a.m. to 3:00 p.m./Eastern Time
(virtual meeting)
• March 9, 2023, from approximately
10:00 a.m. to 3:00 p.m./Eastern Time
(virtual meeting)
• April 12, 2023, from approximately
10:00 a.m. to 3:00 p.m./Eastern Time
(virtual meeting)
• May 17, 2023, from approximately
10:00 a.m. to 3:00 p.m./Eastern Time
(virtual meeting)
• June 15, 2023, from approximately
9:30 a.m. to 4:00 p.m./Eastern Time at
the Mary E. Switzer Federal Building,
Suite 1400, 330 C Street SW,
Washington, DC 20024 (virtual
meeting option available)
• July 13, 2023, from approximately
10:00 a.m. to 3:00 p.m./Eastern Time
(virtual meeting)
• August 17, 2023, from approximately
10:00 a.m. to 3:00 p.m./Eastern Time
(virtual meeting)
• September 14, 2023, from
approximately 10:00 a.m. to 3:00
p.m./Eastern Time (virtual meeting)
• October 19, 2023, from approximately
10:00 a.m. to 3:00 p.m./Eastern Time
(virtual meeting)
• November 9, 2023, from
approximately 9:30 a.m. to 4:00 p.m./
Eastern Time at the Mary E. Switzer
Federal Building, Suite 1400, 330 C
Street SW, Washington, DC 20024
(virtual meeting option available)
All meetings are open to the public.
Additional meetings may be scheduled
as needed. For web conference
instructions and the most up-to-date
information, please visit the HITAC
calendar on the ONC website,
www.healthit.gov/topic/federaladvisory-committees/hitac-calendar.
Contact Person for Meetings: Michael
Berry, Michael.Berry@hhs.gov. A notice
in the Federal Register about last
VerDate Sep<11>2014
18:38 May 23, 2023
Jkt 259001
minute modifications that impact a
previously announced advisory
committee meeting cannot always be
published quickly enough to provide
timely notice. Please email Michael
Berry for the most current information
about meetings.
Agenda: As outlined in the 21st
Century Cures Act, the HITAC will
develop and submit recommendations
to the National Coordinator on the
topics of interoperability, privacy and
security, patient access, and use of
technologies that support public health.
In addition, the committee will also
address any administrative matters and
hear periodic reports from ONC. ONC
intends to make background material
available to the public no later than 24
hours prior to the meeting start time. If
ONC is unable to post the background
material on its website prior to the
meeting, the material will be made
publicly available on ONC’s website
after the meeting, at www.healthit.gov/
hitac.
Procedure: Interested persons may
present data, information, or views,
orally or in writing, on issues pending
before the committee. Written
submissions may be made to the contact
person prior to the meeting date. An
oral public comment period will be
scheduled at each meeting. Time
allotted for each commenter will be
limited to three minutes. If the number
of speakers requesting to comment is
greater than can be reasonably
accommodated during the scheduled
public comment period, ONC will take
written comments after the meeting.
Persons attending in-person HITAC
meetings must register in advance;
virtual attendance is offered as an
alternative. If attending in-person,
please allow time to clear building
security. All visitors will be escorted to
the designated meeting room. Please
note that access to electrical outlets may
be limited or unavailable.
ONC welcomes the attendance of the
public at its HITAC meetings. If you
require special accommodations due to
a disability, please contact Michael
Berry at least seven (7) days in advance
of the meeting.
Notice of these meetings are given
under the Federal Advisory Committee
Act (Pub. L. No. 92–463, 5 U.S.C., app.
2).
Dated: May 12, 2023.
Michael Berry,
Designated Federal Officer, Office of the
National Coordinator for Health Information
Technology.
[FR Doc. 2023–11062 Filed 5–23–23; 8:45 am]
BILLING CODE 4150–45–P
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
33615
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse;
Notice of Closed Meetings
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Drug Abuse Initial Review Group; Career
Development Education and Training Study
Section.
Date: June 29, 2023.
Time: 9:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Health,
National Institute on Drug Abuse, 301 North
Stonestreet Avenue, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Sindhu Kizhakke
Madathil, Ph.D., Scientific Review Officer,
Division of Extramural Research, Scientific
Review Branch, National Institute on Drug
Abuse, NIH, 301 North Stonestreet Avenue,
MSC 6021, Bethesda, MD 20892, (301) 827–
5702, sindhu.kizhakkemadathil@nih.gov.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel; NIDA–
K Alternate SEP.
Date: June 30, 2023.
Time: 12:00 p.m. to 1:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Health,
National Institute on Drug Abuse, 301 North
Stonestreet Avenue, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Marisa Srivareerat, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Office of Extramural Policy, National
Institute on Drug Abuse, NIH, 301 North
Stonestreet Avenue, MSC 6021, Bethesda,
MD 20892, (301) 435–1258,
marisa.srivareerat@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.277, Drug Abuse Scientist
Development Award for Clinicians, Scientist
Development Awards, and Research Scientist
Awards; 93.278, Drug Abuse National
Research Service Awards for Research
Training; 93.279, Drug Abuse and Addiction
Research Programs, National Institutes of
Health, HHS)
E:\FR\FM\24MYN1.SGM
24MYN1
]]>Agencies
[Federal Register Volume 88, Number 100 (Wednesday, May 24, 2023)]
[Notices]
[Pages 33614-33615]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-11062]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Information Technology Advisory Committee 2023 Schedule of
Meetings
AGENCY: Office of the National Coordinator for Health Information
Technology (ONC), HHS.
ACTION: Notice of meetings.
-----------------------------------------------------------------------
SUMMARY: The Health Information Technology Advisory Committee (HITAC)
was established in accordance with the 21st Century Cures Act and the
Federal Advisory Committee Act. The HITAC, among other things,
identifies priorities for standards adoption and makes recommendations
to the National Coordinator for Health Information Technology (National
Coordinator). The HITAC will hold public meetings throughout 2023. See
list of public meetings below.
FOR FURTHER INFORMATION CONTACT: Michael Berry, Designated Federal
Officer, at [email protected], (202) 701-0795.
SUPPLEMENTARY INFORMATION: Section 4003(e) of the 21st Century Cures
Act (Pub. L. 114-255) establishes the Health Information Technology
Advisory Committee (referred to as the ``HITAC''). The HITAC will be
governed by the provisions of the Federal Advisory Committee Act (FACA)
(Pub. L. 92-463), as amended, (5 U.S.C. app.), which sets forth
standards for the formation and use of federal advisory committees.
Composition
The HITAC is comprised of at least 25 members, of which:
No fewer than 2 members are advocates for patients or
consumers of health information technology;
3 members are appointed by the HHS Secretary:
[cir] 1 of whom shall be appointed to represent the Department of
Health and Human Services and
[cir] 1 of whom shall be a public health official;
2 members are appointed by the majority leader of the
Senate;
2 members are appointed by the minority leader of the
Senate;
2 members are appointed by the Speaker of the House of
Representatives;
2 members are appointed by the minority leader of the
House of Representatives; and
Other members are appointed by the Comptroller General of
the United States.
Members serve for one-, two-, or three-year terms. All members may
be reappointed for a subsequent three-year
[[Page 33615]]
term. Each member is limited to two three-year terms, not to exceed six
years of service. Members serve without pay, but will be provided per-
diem and travel costs for committee services, if warranted.
Recommendations
The HITAC recommendations to the National Coordinator are publicly
available at https://www.healthit.gov/topic/federal-advisory-committees/recommendations-national-coordinator-health-it.
Public Meetings
The schedule of meetings to be held in 2023 is as follows:
January 19, 2023, from approximately 10:00 a.m. to 3:00 p.m./
Eastern Time (virtual meeting)
February 8, 2023, from approximately 10:00 a.m. to 3:00 p.m./
Eastern Time (virtual meeting)
March 9, 2023, from approximately 10:00 a.m. to 3:00 p.m./
Eastern Time (virtual meeting)
April 12, 2023, from approximately 10:00 a.m. to 3:00 p.m./
Eastern Time (virtual meeting)
May 17, 2023, from approximately 10:00 a.m. to 3:00 p.m./
Eastern Time (virtual meeting)
June 15, 2023, from approximately 9:30 a.m. to 4:00 p.m./
Eastern Time at the Mary E. Switzer Federal Building, Suite 1400, 330 C
Street SW, Washington, DC 20024 (virtual meeting option available)
July 13, 2023, from approximately 10:00 a.m. to 3:00 p.m./
Eastern Time (virtual meeting)
August 17, 2023, from approximately 10:00 a.m. to 3:00 p.m./
Eastern Time (virtual meeting)
September 14, 2023, from approximately 10:00 a.m. to 3:00
p.m./Eastern Time (virtual meeting)
October 19, 2023, from approximately 10:00 a.m. to 3:00 p.m./
Eastern Time (virtual meeting)
November 9, 2023, from approximately 9:30 a.m. to 4:00 p.m./
Eastern Time at the Mary E. Switzer Federal Building, Suite 1400, 330 C
Street SW, Washington, DC 20024 (virtual meeting option available)
All meetings are open to the public. Additional meetings may be
scheduled as needed. For web conference instructions and the most up-
to-date information, please visit the HITAC calendar on the ONC
website, www.healthit.gov/topic/federal-advisory-committees/hitac-calendar.
Contact Person for Meetings: Michael Berry, [email protected].
A notice in the Federal Register about last minute modifications that
impact a previously announced advisory committee meeting cannot always
be published quickly enough to provide timely notice. Please email
Michael Berry for the most current information about meetings.
Agenda: As outlined in the 21st Century Cures Act, the HITAC will
develop and submit recommendations to the National Coordinator on the
topics of interoperability, privacy and security, patient access, and
use of technologies that support public health. In addition, the
committee will also address any administrative matters and hear
periodic reports from ONC. ONC intends to make background material
available to the public no later than 24 hours prior to the meeting
start time. If ONC is unable to post the background material on its
website prior to the meeting, the material will be made publicly
available on ONC's website after the meeting, at www.healthit.gov/hitac.
Procedure: Interested persons may present data, information, or
views, orally or in writing, on issues pending before the committee.
Written submissions may be made to the contact person prior to the
meeting date. An oral public comment period will be scheduled at each
meeting. Time allotted for each commenter will be limited to three
minutes. If the number of speakers requesting to comment is greater
than can be reasonably accommodated during the scheduled public comment
period, ONC will take written comments after the meeting.
Persons attending in-person HITAC meetings must register in
advance; virtual attendance is offered as an alternative. If attending
in-person, please allow time to clear building security. All visitors
will be escorted to the designated meeting room. Please note that
access to electrical outlets may be limited or unavailable.
ONC welcomes the attendance of the public at its HITAC meetings. If
you require special accommodations due to a disability, please contact
Michael Berry at least seven (7) days in advance of the meeting.
Notice of these meetings are given under the Federal Advisory
Committee Act (Pub. L. No. 92-463, 5 U.S.C., app. 2).
Dated: May 12, 2023.
Michael Berry,
Designated Federal Officer, Office of the National Coordinator for
Health Information Technology.
[FR Doc. 2023-11062 Filed 5-23-23; 8:45 am]
BILLING CODE 4150-45-P
